These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 20486875)

  • 1. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
    Kshirsagar SJ; Bhalekar MR; Umap RR
    Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of enzyme-controlled colonic drug delivery using amylose and hydroxypropyl methylcellulose: optimization by factorial design.
    Kshirsagar SJ; Bhalekar MR; Shewale NS; Godbole VP; Jagdale PK; Mohapatra SK
    Drug Deliv; 2011 Aug; 18(6):385-93. PubMed ID: 21449831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of nanocapsules for colon-targeted drug delivery system.
    Kshirsagar SJ; Bhalekar MR; Patel JN; Mohapatra SK; Shewale NS
    Pharm Dev Technol; 2012; 17(5):607-13. PubMed ID: 21428704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
    Leopold CS; Eikeler D
    J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
    Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
    J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
    Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
    Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
    Kadam VD; Gattani SG
    Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
    Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
    Sinha VR; Mittal BR; Kumria R
    Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
    Patel NV; Patel JK; Shah SH; Patel JN
    Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
    Walter K; von Nieciecki A
    Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multiple-unit tablet containing enteric-coated pellets.
    Dreu R; Ilić I; Srčič S
    Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.
    Schellekens RC; Baltink JH; Woesthuis EM; Stellaard F; Kosterink JG; Woerdenbag HJ; Frijlink HW
    Pharm Dev Technol; 2012; 17(1):40-7. PubMed ID: 20923321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.